Evidence map›Paper›PMID 38484002›Full record

ArticlePloS one2024

Impact of COVID-19-related experiences on health-related quality of life in cancer survivors in the United States.

Amy K Otto, Sarah Prinsloo, Akina Natori, Richard W Wagner, Telma I Gomez, Jewel M Ochoa, Shelley S Tworoger, Cornelia M Ulrich, Sairah Ahmed, Jennifer L McQuade and 5 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02328677 (ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02328677 recruitingnot on this map

ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis

TypeobservationalSponsorUniversity of UtahRan2007 to 2030Enrolled5,000ConditionsColorectal Cancer
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Preguntas Sobre Cáncer (Questions About Cancer): Analysis of Spanish Inquiries to the National Cancer Institute's Cancer Information Service.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Amy K OttoDepartment of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL, United States of America.
Sarah PrinslooDepartment of Palliative, Rehabilitation and Integrative Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America.
Akina NatoriDivision of Medical Oncology, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, United States of America.ORCID 0000-0002-1146-4746
Richard W WagnerDepartment of Palliative, Rehabilitation and Integrative Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America.
Telma I GomezDepartment of Palliative, Rehabilitation and Integrative Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America.
Jewel M OchoaDepartment of Palliative, Rehabilitation and Integrative Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America.
Shelley S TworogerDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States of America.ORCID 0000-0002-6986-7046
Cornelia M UlrichHuntsman Cancer Institute, University of Utah, Salt Lake City, CT, United States of America.
Sairah AhmedDepartment of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America.
Jennifer L McQuadeDepartment of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America.
Anita R PeoplesHuntsman Cancer Institute, University of Utah, Salt Lake City, CT, United States of America.ORCID 0000-0003-3645-3960
Michael H AntoniSylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, United States of America.
Julienne E BowerDepartment of Psychology, University of California Los Angeles, Los Angeles, CA, United States of America.
Lorenzo CohenDepartment of Palliative, Rehabilitation and Integrative Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America.
Frank J PenedoSylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, United States of America.ORCID 0000-0002-2780-0417
The University of Texas MD Anderson Cancer Center · USUniversity of Miami · USUniversity of Utah · USMoffitt Cancer Center · USUniversity of California, Los Angeles · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
Tumor Biology Research ProgramP30CA240139 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Stephen D. Nimer · 2019 to 2026
$24.1M
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare StudyU01CA206110 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jane C. Figueiredo, Christopher I Li · 2016 to 2026
$18.6M
NCI NIH HHS P30 CA016672NCI NIH HHS P30 CA240139NCI NIH HHS U01 CA206110
6 · The paper itself

Abstract

objectiveLittle evidence exists on the impact of the COVID-19 pandemic on cancer survivors, limiting recommendations to improve health-related quality of life (HRQoL) in this population. We describe survivors' pandemic experiences and examine associations between COVID-19-related exposures, psychosocial experiences, and HRQoL.

methodsBetween May 2020-April 2021, survivors completed cross-sectional questionnaires capturing COVID-19-related exposures (e.g., exposure to virus, job loss); psychosocial experiences (i.e., COVID-19-related anxiety/depression, disruptions to health care and daily activities/social interactions, satisfaction with providers' response to COVID, financial hardship, perceived benefits of the pandemic, social support, and perceived stress management ability); and HRQoL.

resultsData were collected from N = 11,325 survivors in the United States. Participants were mostly female (58%), White (89%) and non-Hispanic (88%), and age 63 on average. Breast cancer was the most common diagnosis (23%). Eight percent of participants reported being exposed to COVID-19; 1% tested positive. About 6% of participants lost their jobs, while 24% lost household income. Nearly 30% avoided attending in-person oncology appointments because of the pandemic. Poorer HRQoL was associated with demographic (younger age; female; non-Hispanic White), clinical (Medicare; stage IV disease; hematologic/digestive/respiratory system cancer), and psychosocial factors (low perceived benefits and stress management ability; more disruption to health care and daily activities/social interactions; financial hardship).

conclusionsCOVID-19-related stressors were associated with various psychosocial experiences in cancer survivors, and these psychosocial experiences were associated with HRQoL above and beyond demographic and clinical factors.

Indexed as

Breast NeoplasmsCancer SurvivorsCOVID-19AgedCross-Sectional StudiesFemaleHumansMaleMedicareMiddle AgedPandemicsQuality of LifeUnited States

Identifiers

PMID38484002
PMCPMC10939216
OpenAlexW4392797332

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.